First human clinical trials for nasal vaccine to prevent Alzheimer's disease set to begin

First human clinical trials for nasal vaccine to prevent Alzheimer's disease set to begin A vaccine that could prevent the onset of Alzheimer's disease is beginning its first human clinical trials.

Brigham and Women's Hospital in Boston, Massachusetts, announced on Tuesday that it is starting a Phase I trial of a nasal spray that could prevent the devastating condition. The Daily Mail

See also: 

• Brigham and Women's Hospital Launches Clinical Trial of Nasal Vaccine for Alzheimer's Disease Brigham and Women's Hospital